Theresa (Terry) Toigo serves as CDER’s Associate Director for Drug Safety Operations. She is responsible for the management of significant and timely drug safety issues, as well as the creation and oversight of CDER processes for management of cross-office and cross-Center safety issues.
Immediately before returning to CDER in October 2010, Ms. Toigo served as Director, Office of Special Health Issues (OSHI) for 15 years, working with patients, their advocates, and health professionals to encourage and support their active participation in FDA regulatory decision making. Ms. Toigo joined FDA in 1984 as a Consumer Safety Officer for pulmonary drugs in the Division of Surgical Dental Drug Products. She has held various positions in CDER, the Center for Biologics Evaluation and Research, and the Office of the Commissioner. Ms. Toigo received her bachelor of science degree in pharmacy and a master’s of business administration from Rutgers University. She completed a pharmacy residency at the USPHS Hospital in Staten Island, NY.